At the entrance of a new era, clinical xenotransplantations is a valued and
auspicious option in tackling the problem of donor shortage. Because of et
hical and anatomical issues, domestic farm animals are considered the most
favourable species for organ donation, but transplantation of their organs
leads to a complex process of rejection. Mechanistically, three immunologic
al barriers, namely hyperacute rejection, delayed xenograft rejection and s
ubsequent cellular rejection, are distinguished. A fifth (microbiological)
barrier, is also being recognised. This review focuses on problems regardin
g the fourth barrier i.e. physiology, in possible clinical settings and the
ir corresponding animal models. Besides anatomical differences and posture,
biochemical differences may have a severe impact on recipient survival. Di
fferences in blood components and electrolyte and other biochemical concent
rations are easily detected throughout the species considered for xenotrans
plantation. Enzymes and hormones have complex routes of action, activation
and inhibition, and their molecular differences can impede function. As inf
usion or medicine may correct certain imbalances in electrolytes and protei
ns, problems with complex interactions might be difficult to retrieve and s
olve. Experimentally, survival of discordant xenografts show promising resu
lts, but the first physiological problems have already been detected. So, b
ased upon the few experimental data available and the comparison of veterin
ary physiology, one might expect differences between the organs grafted, re
garding the possible occurrence of physiological problems. Moreover, precau
tions must be taken to extrapolate long-term survival, because of species s
pecificity.